arrow_back Back to App

Refunds for Unused Single-Dose Drugs in Medicare Program

New rules require manufacturers of single-dose drugs covered by Medicare to issue refunds for unused and discarded portions. This aims to reduce waste and save money for the healthcare system, potentially impacting healthcare costs for citizens indirectly.
Key points
Drug manufacturers must refund money for unused portions of single-dose drugs that are discarded.
These changes apply to drugs covered under Medicare Part B, starting January 1, 2022.
Financial penalties will be imposed on manufacturers who fail to comply with the new refund rules.
Refunded amounts will be deposited into the Federal Supplementary Medical Insurance Trust Fund, potentially aiding Medicare's financial stability.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_1287
Sponsor: Sen. Durbin, Richard J. [D-IL]
Process start date: 2021-04-21
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

REFUND Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_1287.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-04-21.

What are the main provisions?

Key points include:

  • Drug manufacturers must refund money for unused portions of single-dose drugs that are discarded.
  • These changes apply to drugs covered under Medicare Part B, starting January 1, 2022.
  • Financial penalties will be imposed on manufacturers who fail to comply with the new refund rules.
  • Refunded amounts will be deposited into the Federal Supplementary Medical Insurance Trust Fund, potentially aiding Medicare's financial stability.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Durbin, Richard J. [D-IL].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health